Structure based drug design of a series of novel 1,4-benzoxazin-3-one derived PARP-1 inhibitors are described. The synthesis, enzymatic & cellular activities and pharmacodynamic effects are described. Optimized analogs demonstrated inhibition of poly-ADP-ribosylation in SW620 tumor bearing nude mice through 24h following a single dose.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bmcl.2013.06.055 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!